| [1] |
.
[J]. Clinical Focus, 2023, 38(7): 654-658.
|
| [2] |
Leng Wantong, Tao Jie.
Risk factors of postoperative venous thromboembolism in patients with multiple myeloma
[J]. Clinical Focus, 2023, 38(4): 340-345.
|
| [3] |
Zhang Lihong, Ma Bing.
Correlation between serum β-CTx and TRACP-5b and the severity and prognosis of multiple myeloma bone disease
[J]. Clinical Focus, 2021, 36(7): 623-627.
|
| [4] |
.
[J]. Clinical Focus, 2016, 31(4): 447-450.
|
| [5] |
Chen Guanghua;Lin Fengru.
Misdiagnosis cause analysis in multiple myeloma
[J]. Clinical Focus, 2015, 30(10): 1120-1122.
|
| [6] |
.
@@
[J]. Clinical Focus, 2015, 30(10): 1186-1188.
|
| [7] |
Li Yingwei;Shen Yuanyuan;Li Sasa;Wang Huiping;Zhang Cui;Qin Hui;Zhai Zhimin.
Ultra small dose decitabine treatment to elderly patients with myelodysplastic syndrome
[J]. Clinical Focus, 2015, 30(7): 773-776.
|
| [8] |
.
[J]. Clinical Focus, 2015, 30(6): 710-714.
|
| [9] |
.
[J]. Clinical Focus, 2015, 30(4): 476-480.
|
| [10] |
.
@@
[J]. Clinical Focus, 2014, 29(12): 1419-0.
|
| [11] |
ZHENG Dong.
Updates on treatment and standard of multiple myeloma
[J]. Clinical Focus, 2014, 29(10): 1130-1133.
|
| [12] |
HAN Xiu-hua;SUN Li-hua;ZOU Jian;MEN Ya-hong;FAN Xiao-hong;WANG Xue-lian.
Protective effect of reduced glutathione on peripheral neuropathy by thalidomide in multiple myeloma
[J]. CLINICAL FOCUS, 2014, 29(4): 410-413.
|
| [13] |
LIU Zhu-zhen;LI Guang-lun;YANG Jie;CUI Zhong-guang.
Effects of different treatments on function of endothelial cells in multiple myeloma patients
[J]. CLINICAL FOCUS, 2014, 29(2): 155-158.
|
| [14] |
.
[J]. Clinical Focus, 2013, 28(1): 102-0.
|
| [15] |
CAO Li-xia;XIAO Zhen;GAO Da.
Clinical observation of bortezomib plus chemothempy in ten patients with multiple myeloma
[J]. Clinical Focus, 2012, 27(24): 2136-2.13721e+007.
|
